Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Lancet (London, England)·2015

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.

The pharmacogenomics journal·2013

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium.

Clinical toxicology (Philadelphia, Pa.)·2013

Genetic variants associated with deep vein thrombosis: the F11 locus.

Journal of thrombosis and haemostasis : JTH·2009

MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.

Lung cancer (Amsterdam, Netherlands)·2009

Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.

The Prostate·2007

Alpha-mannosidase treatment of NK cells does not inhibit NK cell lytic function.

Lymphokine research·1990

TNF-beta (lymphotoxin) strongly upregulates TNF-alpha gene expression in human peripheral blood lymphocytes.

Lymphokine research·1990

Development and characterization of a lyophilized dosage form of IL-1 beta.

Lymphokine research·1990

Expression of interleukin-1 beta in a human keratinocyte cell line.

Lymphokine research·1990

Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta.

Lymphokine research·1990

Synthetic macrophages: liposomes bearing antigen, class II MHC and membrane-IL-1.

Lymphokine research·1990

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Cancer immunology research·2026

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

Inflammatory intestinal diseases·2026

The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: Mechanisms and Therapeutic Potential.

Saudi medical journal·2026

Chrono-immunotherapy in genitourinary oncology: From emerging evidence to clinical translation (Review).

Oncology letters·2026

Astragaloside IV suppresses triple-negative breast cancer cell migration and invasion by targeting BCAT1-mediated branched-chain amino acid metabolism.

Oncology letters·2026

Related Experiment Videos

Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules

Related Concept Videos

Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.

Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.

Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis: an etiology worth considering in the differential diagnosis of delirium.

Genetic variants associated with deep vein thrombosis: the F11 locus.

MRP- and BCL-2-mediated drug resistance in human SCLC: effects of apoptotic sphingolipids in vitro.

Sphingolipids and the sphingosine kinase inhibitor, SKI II, induce BCL-2-independent apoptosis in human prostatic adenocarcinoma cells.

Alpha-mannosidase treatment of NK cells does not inhibit NK cell lytic function.

TNF-beta (lymphotoxin) strongly upregulates TNF-alpha gene expression in human peripheral blood lymphocytes.

Development and characterization of a lyophilized dosage form of IL-1 beta.

Expression of interleukin-1 beta in a human keratinocyte cell line.

Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta.

Synthetic macrophages: liposomes bearing antigen, class II MHC and membrane-IL-1.

TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

Volume change with gantenerumab: Impact of amyloid-related imaging abnormalities and amyloid removal.

Practice Patterns in Inflammatory Bowel Disease in Pakistan: A National Survey of Physician Confidence and Therapeutic Strategies.

The Role of Chimeric Antigen Receptor Regulatory T Cells in Promoting Immune Tolerance in Solid Organ Transplantation: Mechanisms and Therapeutic Potential.

Chrono-immunotherapy in genitourinary oncology: From emerging evidence to clinical translation (Review).

Astragaloside IV suppresses triple-negative breast cancer cell migration and invasion by targeting BCAT1-mediated branched-chain amino acid metabolism.

Related Experiment Videos

Lymphotoxins: a multicomponent system of cell-lytic lymphocyte-released effector molecules

Related Concept Videos

Related Articles